Lucira Health, Inc.
LHDX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $93,055 | $269 | $0 | $0 |
| % Growth | 34,492.9% | – | – | – |
| Cost of Goods Sold | $82,831 | $1,941 | $0 | $0 |
| Gross Profit | $10,224 | -$1,672 | $0 | $0 |
| % Margin | 11% | -621.6% | – | – |
| R&D Expenses | $39,840 | $24,620 | $11,436 | $8,021 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $35,521 | $5,633 | $2,422 | $1,794 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$597 | -$2,145 | -$6,155 | -$3,652 |
| Operating Expenses | $74,764 | $28,108 | $7,703 | $6,163 |
| Operating Income | -$64,540 | -$31,925 | -$13,858 | -$9,815 |
| % Margin | -69.4% | -11,868% | – | – |
| Other Income/Exp. Net | -$270 | -$5,423 | $5,391 | $3,279 |
| Pre-Tax Income | -$64,810 | -$37,348 | -$8,467 | -$6,536 |
| Tax Expense | $17 | $53 | $90 | $190 |
| Net Income | -$64,827 | -$37,401 | -$8,557 | -$6,726 |
| % Margin | -69.7% | -13,903.7% | – | – |
| EPS | -1.86 | -1.04 | -0.56 | -0.44 |
| % Growth | -78.8% | -85.7% | -27.3% | – |
| EPS Diluted | -1.86 | -1.04 | -0.56 | -0.44 |
| Weighted Avg Shares Out | 34,769 | 35,867 | 15,402 | 15,402 |
| Weighted Avg Shares Out Dil | 34,769 | 35,867 | 15,402 | 15,402 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14 | $0 | $0 | $0 |
| Interest Expense | $3 | $53 | $90 | $190 |
| Depreciation & Amortization | $3,685 | $2,425 | $6,438 | $3,901 |
| EBITDA | -$60,525 | -$29,500 | -$7,420 | -$5,914 |
| % Margin | -65% | -10,966.5% | – | – |